Govind Srimathveeravalli

I’ve heard concerns about @theNCI funding in FY26—especially about the number of awards issued so far. Here’s some context. 🧵

@JuliusChapiro Most medical components are built on top of standard/industrial gas/liquid handling ones. McMaster or similar may have tubing that you can repurpose “off label”

Supply chain help request to the IR community: we are extremely short on the CO2 injection tubing, which is on backorder. Despite numerous attempts, we seem unable to find replacements. My supply chain guy asked me to share this and ask if y’all know any suppliers that have this or similar in stock? Anybody know anything?

Courageous and great article from @MSKCancerCenter on Histotripsy published in @cvironco ! Link: link.springer.com/article/10.100… “Patients arrive with predetermined expectations shaped by marketing rather than clinical reality, pressuring physicians to offer treatments lacking comprehensive validation. Healthcare institutions acquire expensive systems to remain competitive, even when clinical need may not justify the investment. Resources are diverted toward technologies with limited proven benefit, while established treatments receive diminished attention.” “Aggressive promotion, driven by commercial interests and capital market pressures, presents theoretical benefits as established advantages. Current histotripsy studies remain predominantly single-center experiences with limited follow-up. The technology’s purported immunologic effects remain entirely theoretical, yet marketing materials present these claims with inappropriate certainty. Patients seek "non-invasive" treatments based on promotional materials overstating capabilities while minimising limitations. This marketing-first approach raises ethical concerns about informed consent and resource allocation.”

@khademh Wow big move! Best of luck for next steps.

After an incredible journey at the Terasaki Institute, I'm excited to announce that I'm stepping into a new chapter focused on entrepreneurship at the intersection of AI and real-world impact. Over the past few years, I've found myself increasingly captivated by the transformative potential of artificial intelligence. What started as curiosity has evolved into a deep conviction about AI's capacity to reshape how we approach fundamental challenges. I've immersed myself fully in understanding not just the technology itself, but how we can harness it to create meaningful change in the world. I believe we're at an inflection point where AI can unlock solutions that were previously out of reach, and I'm thrilled to be part of pushing these boundaries forward. I've already begun this entrepreneurial journey and am energized by what's ahead. I'll be sharing more updates as things develop, and I'm looking forward to building something transformative. For anyone interested in connecting about AI, entrepreneurship, or potential collaborations, please feel free to DM me. I'm always eager to connect with others who share this passion for leveraging technology to make a difference. Here's to new beginnings and the exciting challenges ahead!

news.bloomberglaw.com/health-law-and… More FUD around funding for the coming year …

@drugmonkeyblog Yet paylines have been slashed as though they are following the multiyear mandate. So where’s the money going then?

Is NIH under a Multi-Year funding policy or not? drugmonkey.wordpress.com/2025/09/08/is-… via @drugmonkeyblog

@drugmonkeyblog Been tracking this data for nci. Majority of recent ones are single year awards. Is there any way of parsing what payline and council dates are being funded?

One month to go for NIH grants in the FY2025 cycle drugmonkey.wordpress.com/2025/09/02/one… via @drugmonkeyblog

@drugmonkeyblog I read these with great (self interest). I was tracking some of this for NCI. It appears many multi year awards went to ECI. Based on numbers, there’s should be considerable unspent funds remaining with 6 weeks in the FY.

@jennamueller711 @UMDBIOE @FischellInstUMD @CallaHealth @UMmedschool Congrats! Look forward to seeing the exciting research.

Thrilled our R01 was converted to a 7 year R37 award! This collaborative project between @UMDBIOE @FischellInstUMD @CallaHealth @UMmedschool will enable us to test our low-cost gel ethanol ablation therapy in a phase 1 clinical trial 😎

@BladderCancerUS I did go through the criteria. It did not seem my case was a good fit, I wanted to know if an exception could be made. An email to the contact on the site did not elicit any useful guidance. Ergo the public post on Twitter - which advised me to go read the rfa.

@GovindSLab Without knowing more, it's hard to answer your question. The application criteria are here: bcan.org/research-conti…. Good luck!

PLEASE SHARE -> BCAN has created a fund of up to $1 million to help BC researchers whose federal funding has been interrupted. DEADLINE is 7/18. Click to learn more: bcan.org/research-conti…

@PigiLab @PennMedicine @PennRadiology @SIRspecialists @RSNA @SIO_Central @PennMedNews @PennNSG Sweet! Look forward to amazing research from your group.

Introducing The Kim Lab for Innovation in Image Guided Interventions! 🚨 State of the art technology with ground breaking science. Small and large animal research, device development, industry collaborations, and AR/VR deployment. @PennMedicine @PennRadiology

@manickam_lab @DuquesnePharm @UTHealthHouston Congratulations, best wishes for B exciting new beginnings.

With much gratitude to mentors, collaborators and friends at @DuquesnePharm for years of kind support, I am excited to move our lab to @UTHealthHouston starting fall 2025! Onwards and upwards!

@UberIN_Support Sent DM. Appreciate the prompt response!

@GovindSLab Hi there, this is definitely not the kind of experience we would like you to have. Please send across your registered details via Direct Message, we'll get this addressed at the earliest.

@Uber_India wanted to share feedback on a recent trip but the app is restricted on options. Driver showed up just short of the spot, changed status to arrived but kept playing tag when we tried getting into the car. Uber automatically rebooked another taxi.

Driver then stops for pick up and asks me to cancel the other ride as he can take me to destination. When I boarded asked me to pay cash for the original amount. As uber only allows feedback for completed rides, there’s no way of providing feedback on this person with app. #scam

@mkoeris @DARPA goats as mobile medicinal factories via milk

At @DARPA’s BTO, our mission is to harness biology for national security, from AI-driven protein design to synthetic biology that redefines resilience. Spicy Monday take: If we’re not making our adversaries think twice (or three times!) about getting at us, we’re not meeting the mission! Anticipate and create surprise! That’s the mission. 🫡🇺🇸 What’s the craziest idea you got on a Monday?

@abandopa I am not in India but am very much involved in medtech startups here. Would love to be part of this for. Please let me know if I can join.

I am trying to build a WhatsApp Community for MedTech startups and ecosystem enablers. If you are one of these brave Indians, will you be kind enough to share your WhatsApp contact with me? I will take the responsibility of ensuring that it remains a strictly professional group.

@ozumarzik Short form fiction, also known as my Twitter feed.

Reading on translation on my way back home.I found it in a second hand bookshop in Chicago.What are you reading? #translation #academia #1nt #terps

@draparente @eric_is_weird I like doing the research and literature reviews. I can go down interesting rabbit holes and make connections that go beyond the query. Filling paperwork, placing orders, generating annual reports, writing protocols and answer emails would free up so much of my productive time

Say this all the time - ops/admin could be initial use cases. If there was a tool that let PIs be PIs that would be extremely impactful for scientific productivity and student training. What areas do you think would be most impactful? - RFA scouting - grant progress report support (eg generate reports from data PowerPoints) - anything for study sections? - administrative forms and reporting automation, due date tracking, etc

If somebody gave a founder ~10 years of runway and $2 million/year to continually build + deploy tools that made LLMs increasingly essential in Cambridge, MA academic labs, what would you build?